NCT07039474View on ClinicalTrials.gov

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 1, 2027

Conditions

Solid Tumors and Hematological Tumors

Interventions

DRUG

18F-G1

18F-G1 is injected intravenously with a dose of 0.06-0.08mCi/kg

All Listed Sponsors

lead

Peking University First Hospital

OTHER